This spectrum consists of isolated hepatic macrovesicular steatosis at one end and nonalcoholic steatohepatitis (NASH) at the other. Hepatic steatosis is present in ~50% of the subjects with HCV.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback